Participation of low-income women in genetic cancer risk assessment and BRCA 1/2 testing: the experience of a safety-net institution

被引:30
|
作者
Komenaka I.K. [1 ,2 ]
Nodora J.N. [3 ]
Madlensky L. [3 ]
Winton L.M. [1 ]
Heberer M.A. [1 ]
Schwab R.B. [3 ]
Weitzel J.N. [4 ]
Martinez M.E. [3 ]
机构
[1] Maricopa Medical Center, Hogan Building, 2nd Floor, 2601 E Roosevelt Street, Phoenix, 85008, AZ
[2] Arizona Cancer Center, University of Arizona, Tucson, AZ
[3] University of California, San Diego, Moores Cancer Center, La Jolla, CA
[4] Division of Clinical Cancer Genetics, City of Hope, Duarte, CA
基金
美国国家卫生研究院;
关键词
Disparity; Genetic cancer risk assessment; Hispanic; Latina; Minority; Underinsured;
D O I
10.1007/s12687-015-0257-x
中图分类号
学科分类号
摘要
Some communities and populations lack access to genetic cancer risk assessment (GCRA) and testing. This is particularly evident in safety-net institutions, which serve a large segment of low-income, uninsured individuals. We describe the experience of a safety-net clinic with limited resources in providing GCRA and BRCA1/2 testing. We compared the proportion and characteristics of high-risk women who were offered and underwent GCRA and genetic testing. We also provide a description of the mutation profile for affected women. All 125 patients who were offered GCRA accepted to undergo GCRA. Of these, 72 % had a breast cancer diagnosis, 70 % were Hispanic, 52.8 % were non-English speakers, and 66 % did not have health insurance. Eighty four (67 %) were offered genetic testing and 81 (96 %) agreed. Hispanic women, those with no medical insurance, and those with a family history of breast cancer were significantly more likely to undergo testing (p > 0.01). Twelve of 81 (15 %) patients were found to have deleterious mutations, seven BRCA1, and five BRCA2. Our experience shows that it is possible to offer GCRA and genetic testing even in the setting of limited resources for these services. This is important given that a large majority of the low-income women in our study agreed to undergo counseling and testing. Our experience could serve as a model for similar low-resource safety-net health settings. © 2015, Springer-Verlag Berlin Heidelberg.
引用
收藏
页码:177 / 183
页数:6
相关论文
共 50 条
  • [31] Cancer risk management strategies and perceptions of unaffected women 5 years after predictive genetic testing for BRCA1/2 mutations
    Claire Julian-Reynier
    Julien Mancini
    Emmanuelle Mouret-Fourme
    Marion Gauthier-Villars
    Valérie Bonadona
    Pascaline Berthet
    Jean-Pierre Fricker
    Olivier Caron
    Elisabeth Luporsi
    Catherine Noguès
    European Journal of Human Genetics, 2011, 19 : 500 - 506
  • [32] Cancer risk management strategies and perceptions of unaffected women 5 years after predictive genetic testing for BRCA1/2 mutations
    Julian-Reynier, Claire
    Mancini, Julien
    Mouret-Fourme, Emmanuelle
    Gauthier-Villars, Marion
    Bonadona, Valerie
    Berthet, Pascaline
    Fricker, Jean-Pierre
    Caron, Olivier
    Luporsi, Elisabeth
    Nogues, Catherine
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2011, 19 (05) : 500 - 506
  • [33] Breast cancer in women at high risk: The role of rapid genetic testing for BRCA1 and-2 mutations and the consequences for treatment strategies
    Francken, Anne Brecht
    Schouten, Philip C.
    Bleiker, Eveline M. A.
    Linn, Sabine C.
    Rutgers, Emiel J. Th.
    BREAST, 2013, 22 (05): : 561 - 568
  • [34] A gift or a yoke? Women's and men's responses to genetic risk information from BRCA1 and BRCA2 testing
    d'Agincourt-Canning, L.
    CLINICAL GENETICS, 2006, 70 (06) : 462 - 472
  • [35] Modes of delivery of genetic testing services and the uptake of cancer risk management strategies in BRCA1 and BRCA2 carriers
    Pal, T.
    Lee, J-H
    Besharat, A.
    Thompson, Z.
    Monteiro, A. N. A.
    Phelan, C.
    Lancaster, J. M.
    Metcalfe, K.
    Sellers, T. A.
    Vadaparampil, S.
    Narod, S. A.
    CLINICAL GENETICS, 2014, 85 (01) : 49 - 53
  • [36] Attitudes and distress levels in women at risk to carry a BRCA1/BRCA2 gene mutation who decline genetic testing
    Lodder, L
    Frets, PG
    Trijsburg, RW
    Klijn, JGM
    Seynaeve, C
    Tilanus, MMA
    Bartels, CCM
    Meijers-Heijboer, EJ
    Verhoog, LC
    Niermeijer, MF
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2003, 119A (03): : 266 - 272
  • [37] Effective Referral of Low-Income Women at Risk for Hereditary Breast and Ovarian Cancer to Genetic Counseling: A Randomized Delayed Intervention Control Trial
    Pasick, Rena J.
    Joseph, Galen
    Stewart, Susan
    Kaplan, Celia
    Lee, Robin
    Luce, Judith
    Davis, Sharon
    Marquez, Titas
    Tung Nguyen
    Guerra, Claudia
    AMERICAN JOURNAL OF PUBLIC HEALTH, 2016, 106 (10) : 1842 - 1848
  • [38] Effects of coping style and BRCA1 and BRCA2 test results on anxiety among women participating in genetic counseling and testing for breast and ovarian cancer risk
    Tercyak, KP
    Lerman, C
    Peshkin, BN
    Hughes, C
    Main, D
    Isaacs, C
    Schwartz, MD
    HEALTH PSYCHOLOGY, 2001, 20 (03) : 217 - 222
  • [40] Subjective and objective risk of ovarian cancer in Ashkenazi Jewish women testing for BRCA1/2 mutations
    Kelly, Kimberly M.
    Senter, Leigha
    Leventhal, Howard
    Ozakinci, Gozde
    Porter, Kyle
    PATIENT EDUCATION AND COUNSELING, 2008, 70 (01) : 135 - 142